Overview
Aki Sato practices in Tokyo, Japan. Sato is highly rated in 2 conditions, according to our data. Their top areas of expertise are Reticulohistiocytoma, Histiocytosis, Langerhans Cell Histiocytosis, and Clear Cell Sarcoma.
Their clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HistiocytosisSato isAdvanced. Learn about Histiocytosis.
- ReticulohistiocytomaSato isAdvanced. Learn about Reticulohistiocytoma.
- Experienced
- Acute Interstitial Pneumonia
- ADULT SyndromeSato isExperienced. Learn about ADULT Syndrome.
- Adult T-Cell LeukemiaSato isExperienced. Learn about Adult T-Cell Leukemia.
- Clear Cell SarcomaSato isExperienced. Learn about Clear Cell Sarcoma.
- Erdheim-Chester DiseaseSato isExperienced. Learn about Erdheim-Chester Disease.
- Interstitial Lung DiseaseSato isExperienced. Learn about Interstitial Lung Disease.